AdAlta (ASX:1AD) Share Price and News - StockTrack

Market Cap (19-Sep) $7,649,007 (1,598th)	Close (30-Jun) $0.024 0 (0%)	Volume (30-Jun) 2,170,184	Shortsold (2-Feb) 3,141 (0.00%) (662nd)
52w High $0.008	52w Low $0.002	P/E -	EPS 0

	Subject
	1AD 1AD Ann: R&D Tax Incentive Refund received
	1 (current) 2 3
	1AD 1AD Ann: Notification of Date of 2022 AGM
	1AD 1AD Ann: Appendix 4G and Corporate Governance Statement
	1AD 1AD Ann: Annual Report to shareholders
	1AD 1AD Ann: Preliminary Final Report
	1AD 1AD Ann: Sydney Investor Briefing Invitation
	1AD 1AD Ann: Company Presentation
	1AD 1AD Ann: Quarterly Appendix 4C and Activities Report
	1AD 1AD Ann: Notification regarding unquoted securities - 1AD
	1AD 1AD Ann: Notification of cessation of securities - 1AD
	1AD 1AD Ann: AD-214 program update, cash runway extension
	1AD 1AD Ann: European Patent for AD-214 granted
	1AD 1AD Ann: BIO International Convention presentation
	1AD 1AD Ann: AdAlta presentation at Bioshares Biotech Summit
	1AD 1AD Ann: Indian patent for AD-214
	1AD 1AD Ann: Inhaled AD-214 preclinical program
	1AD 1AD Ann: PAC Partners Healthcare Conference - Corporate Presentation
	1AD 1AD Ann: Quarterly Appendix 4C and Activities Report
	1AD 1AD Ann: Notification regarding unquoted securities - 1AD
	1AD 1AD Ann: Notification of cessation of securities - 1AD
	1AD 1AD Ann: $1.6M Second Tranche R&D Cash Flow Loan Received
	1AD 1AD Ann: Chinese patent granted for AD-214
	1AD 1AD Ann: Half Yearly Report and Accounts
	1AD 1AD Ann: Adjustment to Option Exercise Prices
	1AD 1AD Ann: Change in Director Interest Notice x 4
	1AD 1AD Ann: Application for quotation of securities - 1AD
	1AD 1AD Ann: Entitlement Offer Results
	1AD 1AD Ann: Quarterly Appendix 4C and Activities Report
	1AD 1AD Ann: Presentation to Share Cafe Webinar
	1AD 1AD Ann: Retraction of Slide in Presentations
	1AD 1AD Ann: Presentation Conference Schedule - January 2022
	1AD 1AD Ann: Change in substantial holding
	1AD 1AD Ann: Cleansing Notice - Entitlement Offer
	1AD 1AD Ann: Entitlement Offer Booklet
	1AD 1AD Ann: Entitlement Offer - Letter to Ineligible Shareholders
	1AD 1AD Ann: Entitlement Offer - Letter to shareholders
	1AD 1AD Ann: Change in substantial holding
	1AD 1AD Ann: Cleansing Notice - Placement
	1AD 1AD Ann: Application for quotation of securities - 1AD
	1AD 1AD Ann: Letter to Optionholders
	1AD 1AD Ann: Cleansing Notice - Entitlement Offer
	1AD 1AD Ann: Reinstatement to Quotation
	1AD 1AD Ann: Cash Position and Corporate Presentation
	1AD 1AD Ann: Placement raises $3.75million
	1AD 1AD Ann: Proposed issue of securities - 1AD
	1AD 1AD Ann: Proposed issue of securities - 1AD
	1AD 1AD Ann: Voluntary Suspension
	1AD 1AD Ann: Trading Halt
	1AD 1AD Ann: Inhaled AD-214 passes first development milestone
	1AD 1AD Ann: Change in Director Interest Notice x 4

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.00	11,589,500	0.00 (0.00%)
12-Sep	$0.00	477,000	0.00 (0.00%)
11-Sep	$0.00	4,503,439	0.00 (0.00%)
05-Sep	$0.00	0	0.00 (0.00%)
04-Sep	$0.00	397,500	0.00 (0.00%)
03-Sep	$0.00	8,553,500	0.00 (25.00%)
29-Aug	$0.00	496,263	0.00 (0.00%)
28-Aug	$0.00	799,825	0.00 (20.00%)
22-Aug	$0.01	6,410,928	+0.00 (25.00%)
21-Aug	$0.00	2,372,593	+0.00 (60.00%)
15-Aug	$0.00	4,667,230	0.00 (0.00%)
14-Aug	$0.00	2,990,568	0.00 (16.67%)
07-Aug	$0.00	118	+0.00 (20.00%)
31-Jul	$0.00	75,962	+0.00 (25.00%)
30-Jul	$0.00	1,666,667	0.00 (0.00%)
4 up, 3 down, and 8 flat days

High $0.03	Low $0.02	Trades 24	Turnover $54,432	Volume 2,170,184
30 June 2023 at 3:59pm

High $0.03	Low $0.02	Trades 24	Turnover $54,432	Volume 2,170,184
30 June 2023 at 3:59pm

AdAlta Health Care

$0.024 (0%)

$0.024 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices